Home/ Stocks/ LAB

Standard BioTools Inc. Common Stock

LAB XNAS

$0.80 -0.00 (-0.01%) ▼ 15-min delayed

Open

$0.78

High

$0.82

Low

$0.78

Volume

729.0K

Market Cap

$314.10M

About Standard BioTools Inc. Common Stock

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 389 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$20.10M	$-26,758,000	$-0.07
Q1 2026	$21.15M	$127.07M	$0.33
FY 2025	$85.33M	$-74,896,000	$-0.20
Q3 2025	$19.55M	$-34,687,000	$-0.09

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for LAB yet. Check out our latest market news or earnings calendar.

Get LAB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Standard BioTools Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.